Purification of IgG anti-Ts5 antibodies. by Felipe Cerni (3477902)

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for Brazil. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Caribbean. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Southern Cone. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Andean region. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Mesoamerican region. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the whole LAC region. by Santiago Avila-Rios (3160959)

Subjects:

Three-, bi- and mono-functional Vγ9Vδ2 T-cell subsets decrease in HIV+ patients. by Rita Casetti (608635)

Fig 2 - by Calvin P. Philp (12095878)

Subjects:

Fig 3 - by Calvin P. Philp (12095878)

Subjects:

Effect of anthocyanin-rich fraction, as compared with 5-ASA, on body weight and on macroscopic colonic damage in rats with TNBS-induced colitis. by Sónia R. Pereira (3854467)

Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders by Ajay Singh (227970)

Quantitation of the decrease in viability of schistosomula caused by GSK343 treatment at different concentrations and incubation times. by Adriana S. A. Pereira (5900249)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Sequences predicted to form an RNA panhandle structure between the 5′ and 3′ termini play a role in S1 packaging. by Debarpan Dhar (724473)

The GmNN1/FT2a-GmNFYA-C-GmENOD40 module regulates soybean nodulation. by Xinxin Li (281237)

Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”

Increased serum EN-RAGE and decreased serum sRAGE are associated with COPD disease severity. by Debra A. Cockayne (158612)

CF-BECs demonstrate little change in viability after infection with PA at a dilution of 2 x 10² the OD 0.5 after 24 hours. by Meghan J. Hirsch (16528311)

F1 pre-dissolution, pH 6, pH 5, and pH 4 thin sections of cortical and trabecular bone. by Colleen A. Sullivan (13955253)